A hitherto unidentified N-ethyl-N-nitrosourea (ENU)-induced mutation affects dorsal root ganglia (DRG) formation in ouchless mutant zebrafish larvae. In contrast to previous findings assigning the ouchless phenotypes to downregulated sorbs3 transcript levels, this work re-attributes the phenotypes to an essential splice site mutation affecting adgra2 (gpr124) splicing and function. Accordingly, ouchless mutants fail to complement previously characterized adgra2 mutants and exhibit highly penetrant cerebrovascular defects. The aberrantly spliced adgra2 transcript found in ouchless mutants encodes a receptor lacking a single leucine-rich repeat (LRR) within its N-terminus.
In a research article published in Development, Malmquist et al. (2013) phenotypically characterized the ouchless mutant that was recovered from an F3 forward genetic screen for defective dorsal root ganglion (DRG) neurogenesis. While the initial dorsoventral migration of neural crest-derived cell clusters towards presumptive DRG locales appears unaffected in ouchless mutants, the neurogenic program leading to the generation of neurog1:EGFP + cells within the ganglion is defective, resulting in a severe reduction of DRG numbers in 72 hours post fertilization (hpf ) ouchless mutants. ouchless mutants are viable but exhibit reduced growth rates and interrupted melanophore stripes in the adult skin. The ouchless mutation was mapped by bulk segregation analysis to a 342 kb genomic region of chromosome 8, harboring the sorbs3 gene. No causative mutation could be identified within the coding sequence of sorbs3, but a mutation was suspected to reside within cis-regulatory elements, accounting for the reduced sorbs3 transcript levels observed in ouchless mutants. Antisense sorbs3 morpholino knockdown experiments, as well as BAC and mRNA rescue experiments, further supported the model that sorbs3 regulates DRG neurogenesis and that sorbs3 dysfunction drives the ouchless phenotypes (Malmquist et al., 2013) .
The ouchless phenotypes are remarkably analogous to the DRG defects reported in adgra2 (previously known as gpr124) mutants (Vanhollebeke et al., 2015) . Adgra2 is a newly discovered Wnt7specific co-activator of Wnt/β-catenin signaling (Posokhova et al., 2015; Vanhollebeke et al., 2015; Zhou and Nathans, 2014) . Along with Reck, it has been shown to control DRG formation by activating Wnt signaling in neural crest-derived sox10:mRFP + ganglion cells (Vanhollebeke et al., 2015) . In addition, Adgra2 and Reck function as essential regulators of brain vascular development by promoting Wnt/ β-catenin signaling in cerebrovascular endothelial cells (ECs) (Posokhova et al., 2015; Ulrich et al., 2016; Vanhollebeke et al., 2015; Zhou and Nathans, 2014) . While the pivotal role of these proteins in cerebrovascular development is established both in the zebrafish and the mouse model (Anderson et al., 2011; Cullen et al., 2011; de Almeida et al., 2015; Kuhnert et al., 2010; Noda et al., 2016; Posokhova et al., 2015; Ulrich et al., 2016; Vanhollebeke et al., 2015; Zhou and Nathans, 2014) , the molecular mechanisms underlying their activation and signal transduction remain to be determined. Given the phenotypic similarities, we therefore set out to test whether adgra2 and ouchless ( presumably sorbs3) co-operate during the process of DRG neurogenesis and brain vascularization.
We first tested whether adgra2 and ouchless genetically interact by functional gene dosage experiments. Fish heterozygous for ouchless were crossed with the previously described adgra2 heterozygotes, adgra2 s984/+ and adgra2 s985/+ , and the offspring were assessed at 72 hpf for defects in DRG neurogenesis. From these crosses, ∼25% of the offspring (annotated as ouchless/ adgra2 s984 and ouchless/adgra2 s985 ) showed an almost complete lack of neurog1:EGFP + DRG (Fig. 1A ,A′). When raised to adulthood, these fish could be distinguished from their siblings by discontinuous dorsal melanophore stripes on their skin ( Fig. 1A , brackets). As Adgra2 controls brain angiogenesis, we analyzed the cerebral vasculature of 60 hpf embryos derived from ouchless heterozygotes incrosses and outcrosses to adgra2 heterozygotes. Strikingly, 25% of the offspring of each of the crosses displayed highly penetrant brain vascular defects, characterized by a complete absence of central arteries (CtAs), similar to adgra2 mutants ( Fig. 1B,B′) . Further assessment using Wnt/β-catenin signaling reporter lines linked this phenotype to defective endothelial Wnt/βcatenin signaling in the perineural primordial hindbrain channel (PHBC) ECs (Fig. 1C ). The lack of complementation between ouchless and adgra2, together with the discovery of vascular phenotypes in ouchless mutants that mimic those of adgra2 mutants, raised the possibility that ouchless constitutes a new allele of adgra2. Accordingly, when ouchless mutants were injected at the one-cell stage with mRNA encoding wild-type (WT) Adgra2, significant restoration of neurog1:EGFP + DRG (Fig. 1D ,E) and cerebral blood vessels was observed ( Fig. 1D,F) .
We then re-evaluated the genomic region known to harbor the ouchless mutation and discovered that the adgra2 gene resides within the critical interval, spanning the ca-48 and ca-37 genomic markers ( Fig. 2A ). This information was missing in the original characterization of the ouchless mutants owing to incomplete genome assembly and annotation at the time of analysis (Malmquist et al., 2013) . We cloned the full-length adgra2 coding sequence from ouchless mutants and evaluated the capacity of this allele to rescue DRG and CtA defects in adgra2 morphants by mRNA injection at the one-cell stage. While mRNA encoding the WT receptor (annotated as adgra2) partially suppressed both phenotypes, the ouchless variant (annotated as adgra2 ouchless ) did not affect either (Fig. 2D,E) . Of note, the experiments were performed in morphants rather than mutants in order to increase the number of observations and hence the strength of the statistical analyses. The adgra2 morpholino sequence and dosage used in this study were previously validated to ensure that phenotypic suppression values in morphant and mutant genetic backgrounds do not statistically differ (Vanhollebeke et al., 2015) .
In order to identify the inactivating mutation, we compared a reference WT adgra2 allele with the adgra2 coding sequence recovered from ouchless mutant embryos. This analysis revealed four non-synonymous single nucleotide polymorphisms (SNPs; M429V, S895P, A1282V and A1302G) as well as an in-frame 72 bp deletion corresponding to exon 4 ( Fig. 2C,F) . While all four adgra2 SNPs identified in ouchless mutants had been previously identified in functionally validated adgra2 alleles derived from mixed AB/TL genetic backgrounds, alternative splicing resulting in exon 4 skipping is absent from any known zebrafish, mouse or human ADGRA2 isoform. When probed in zebrafish, alternative splicing of the exon 1-exon 6 sequences is undetectable by RT-PCR (Fig. 2C ) or by Sanger sequencing of full-length adgra2 coding sequences derived from WT larvae (data not shown). Exon 4 corresponds precisely to the third leucine-rich repeat (LRR) unit of the LRR/CT domain of Adgra2, which comprises an array of four 24-residuelong LRR units followed by a LRR cysteine-rich C-terminal motif (LRR-CT) (Fig. 2F ). Exon-protein domain correlations are recurrent amongst eukaryotes and reflect an efficient mechanism for protein modular functionalization through exon shuffling. The genomic structure of ADGRA2 is evolutionary conserved, with LRR units precisely matching exons 2 to 5 in zebrafish, mouse and human (Fig. 2C) . Sanger sequencing of genomic regions flanking adgra2 ouchless exon 4 identified an essential 5′ splice donor site mutation (GT→TT) at the exon 4-intron 4 boundary, which probably accounts for the exon 4 skipping event (Fig. 2B) .
To confirm that the in-frame deletion of exon 4 leads to Adgra2 inactivation, we reproduced this deletion in a WT allele of adgra2 by mutagenesis and evaluated the functionality of the resulting variant, adgra2 ΔLRR3 , in transient rescue assays. Injections of 100 pg of adgra2 ouchless or adgra2 ΔLRR3 mRNA into adgra2 morphants at the one-cell stage did not yield detectable rescuing neurogenic or angiogenic activity (Fig. 2D,E) . This indicates that Adgra2 lacking LRR3 is functionally null. In light of this evidence, the fact that a limited number of DRG neurons develop in ouchless mutants, but not in the adgra2 s984 and adgra2 s985 frame-shift mutants, appears puzzling (Fig. 1A,A′) . We speculate that the residual ouchless DRG neurons result either from a minor pool of normally spliced transcripts or from a cryptic splice-site activation event restoring a functional allele. However, these events must be very rare and tissue specific, as brain vascular defects of the ouchless and frame-shift mutants are equally penetrant and only the transcript lacking exon 4 could be amplified from 48 hpf ouchless mutants (Fig. 2C) . Altogether, this work reveals that ouchless and adgra2 mutants are allelic and that the ouchless phenotypes result from an essential splice site mutation inactivating Adgra2 through the in-frame deletion of a single LRR in the ectodomain of this adhesion G-protein coupled receptor (GPCR). Further characterization of the ouchless allele suggests that the lack of this LRR motif impairs trafficking of Adgra2 (Bostaille et al., 2016) . Malmquist et al. (2013) previously attributed the ouchless phenotypes to defective sorbs3 function based on convergent evidence from genomic mapping approaches, partial phenotypic rescue after ectopic Sorbs3 expression from cDNA or BAC templates as well as loss-of-function morpholino analyses. sorbs3 was additionally reported to genetically interact with erbb3 signaling in the process of DRG neurogenesis. We note that, while our current work unambiguously re-assigns the ouchless phenotypes to defective adgra2 rather than sorbs3, it does not per se exclude (nor confirm) a role for sorbs3 or erbb3 in Adgra2-controlled DRG neurogenesis. However, in light of the genetic evidence presented here, a careful re-evaluation of their contribution to the ouchless phenotypes is warranted.
MATERIALS AND METHODS

Zebrafish strains and cell lines
Zebrafish (Danio rerio) were raised and maintained under standard conditions. The following lines were used: AB, TL, Tg(kdrl:GFP) s843 (Jin et al., 2005) , Tg(kdrl:ras-mCherry) s896 (Chi et al., 2008) , Tg(7xTCF-Xla. Siam:GFP) ia4 (Moro et al., 2012) , Tg(-17.0neurog1:EGFP) w61 (McGraw et al., 2008) , ouchless (sorbs3 w35 ) (Malmquist et al., 2013) , adgra2 s984 and adgra2 s985 (Vanhollebeke et al., 2015) , as reported previously. All animal experiments were performed in accordance with the rules of the State of Belgium ( protocol approval number: CEBEA-IBMM-2012:65).
Cloning strategy, morpholino and RNA expression constructs
The adgra2 ΔLRR3 deletion mutant was generated by In-Fusion cloning (Takara, Mountain View, CA) and the deletion corresponds to amino acids 125-148. Capped messenger RNAwas synthesized using the mMESSAGE mMACHINE kit (Ambion, Carlsbad, CA). In all panels, one-cell-stage embryos were injected either with 100 pg of the indicated mRNA or 4 ng of a previously validated adgra2 splice-blocking morpholino (Vanhollebeke et al., 2015) .
Imaging
Images were acquired on a Zeiss LSM710 confocal microscope. Threedimensional representations were generated using Imaris FilamentTracer software (BitPlane, Zurich, Switzerland).
Statistical analysis
Statistical analyses were performed using the GraphPad Prism software. Sample size was determined with G*power v.3.1.5 software to reach adequate statistical power. Each dot plot value represents an independent embryo and every experiment was conducted three times independently. P-values were calculated by the Kruskal-Wallis test ( post hoc Dunn's test).
